The market prospect of the hottest plastic drug pa

2022-09-22
  • Detail

It is reported that the annual GDP of China's pharmaceutical packaging materials will quickly exceed 20billion yuan in the short term. Such a large cake will make enterprises happy to get a part of the loading time. However, the existing packaging materials of many plastic drug packaging materials enterprises are backward and the market chaos is quite serious, especially compared with the emerging new dosage forms, the matching drug packaging materials follow-up speed is too slow, which makes them unable to be so proud of the market

some experts predict that the next five years will be a critical period for the rapid development of China's pharmaceutical packaging industry. At present, the annual output value of China's pharmaceutical packaging industry is about 15billion yuan, which can only meet about 80% of the needs of domestic pharmaceutical enterprises, which promotes the rapid development of the plastic pharmaceutical packaging industry in recent years. However, it is also for this reason that some software conditions supporting this pharmaceutical peripheral industry have lagged behind and can not keep up with its development pace. At present, the compatibility test between new pharmaceutical preparations and new plastic packaging materials needs to be improved urgently in China. The relevant person of Nanfang Packaging Co., Ltd. said: "such tests are generally carried out by us for customers now, with a very long cycle and a large investment in human and material resources." It is reported that there are not many domestic pharmaceutical packaging material manufacturers that have the ability to undertake such businesses, such as Nanfang packaging

it is understood that at present, most of the existing plastic drug packaging material production enterprises in China are township collective enterprises, which are small in scale, low in personnel quality, equipment, technology and management level, unstable in product quality. Adopting the cascade tightening mechanism and cold technology will definitely cause disorderly competition in the market. In order to reduce costs, some enterprises secretly buy a large number of low-cost and low-quality products. For example, the same kind of composite membrane has been produced in the clean plant for more than 10 years according to the regulations. The room production has special properties that ordinary particle size does not have, and the cost is about 22000 yuan/ton, while the production in the "underground factory" has a maximum cost of only 18000 yuan/ton

Xinchang County, Zhejiang Province is known as the "hometown of capsules" in China, and its annual output once accounted for 1/3 of the country in the 1980s. However, among the 327 capsule production enterprises in Xinchang County, there are 299 unlicensed enterprises, 90% of which are in the "low, small and scattered" business situation, of which more than 40% of the capsule production enterprises belong to individual enterprises, and family workshops occupy the dominant position

it is understood that at present, some large-scale enterprises are unable to do anything about the chaotic market situation. They have begun to seek diversified development and turned to exploring packaging opportunities in the food industry. As for the expansion of drug packaging production, they believe that they still need to wait for the country to further rectify and regulate the market

Copyright © 2011 JIN SHI